These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30811495)

  • 1. Replacing P-values with frequentist posterior probabilities of replication-When possible parameter values must have uniform marginal prior probabilities.
    Llewelyn H
    PLoS One; 2019; 14(2):e0212302. PubMed ID: 30811495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M; Takahashi F; Kawasaki Y
    Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
    Zaslavsky BG
    Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2010 Sep; 20(5):985-97. PubMed ID: 20721786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate use of statistical power.
    Fraser RA
    Bone Marrow Transplant; 2023 May; 58(5):474-477. PubMed ID: 36869191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living with p values: resurrecting a Bayesian perspective on frequentist statistics.
    Greenland S; Poole C
    Epidemiology; 2013 Jan; 24(1):62-8. PubMed ID: 23232611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To P or Not to P: Backing Bayesian Statistics.
    Buchinsky FJ; Chadha NK
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):915-918. PubMed ID: 29192853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian Meta-Analysis for Binary Data and Prior Distribution on Models.
    Negrín-Hernández MA; Martel-Escobar M; Vázquez-Polo FJ
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33477861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Détente: A Practical Understanding of P values and Bayesian Posterior Probabilities.
    Ruberg SJ
    Clin Pharmacol Ther; 2021 Jun; 109(6):1489-1498. PubMed ID: 32748400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of branch length uncertainty on Bayesian posterior probabilities for phylogenetic hypotheses.
    Kolaczkowski B; Thornton JW
    Mol Biol Evol; 2007 Sep; 24(9):2108-18. PubMed ID: 17636043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rating exposure control using Bayesian decision analysis.
    Hewett P; Logan P; Mulhausen J; Ramachandran G; Banerjee S
    J Occup Environ Hyg; 2006 Oct; 3(10):568-81. PubMed ID: 16998991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branch-length prior influences Bayesian posterior probability of phylogeny.
    Yang Z; Rannala B
    Syst Biol; 2005 Jun; 54(3):455-70. PubMed ID: 16012111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian non-inferiority test for two independent binomial proportions.
    Kawasaki Y; Miyaoka E
    Pharm Stat; 2013; 12(4):201-6. PubMed ID: 23625633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.